Aspira Pathlab & Diagnostics Ltd.
| BSE: 540788 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE500C01017 |
| BSE 00:00 | 04 Jan | 26.75 |
0 (0.00%) |
OPEN
26.75 |
HIGH
26.75 |
LOW
26.75 |
| NSE 05:30 | 01 Jan | Aspira Pathlab & Diagnostics Ltd |
| OPEN | 26.75 |
| PREVIOUS CLOSE | 26.75 |
| VOLUME | 100 |
| 52-Week high | 38.30 |
| 52-Week low | 20.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 25 |
| Buy Price | 26.75 |
| Buy Qty | 400.00 |
| Sell Price | 24.30 |
| Sell Qty | 10.00 |
Aspira Pathlab & Diagnostics Ltd. (ASPIRAPATHLAB) - Announcements
-
Aspira Pathlab & Diagnostics Ltd Shareholding for the Period Ended January 07 2021
16/01/2021 | bse
-
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
14/01/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
14/01/2021 | bse
-
Aspira Pathlab & Diagnostics Ltd Shareholding for the Period Ended December 31 2020
13/01/2021 | bse
-
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
13/01/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13/01/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
11/01/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
11/01/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
11/01/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
11/01/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Allotment
07/01/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Closure of Trading Window
31/12/2020 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Non-Applicability Of Related Party Transactions Under Regulation 23 (9) Of SEBI (Listing Obligations
26/11/2020 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Unaudited Financial Results For The Quarter Ended September 30 2020
10/11/2020 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Outcome Of Meeting Of The Board Of Directors Held On November 10 2020 Pursuant To Regulation 30 Of S
10/11/2020 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Compliance Under Regulation 47 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulatio
04/11/2020 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Board Meeting Intimation for Under Regulation 29 Of The Securities And Exchange Board Of India (List
03/11/2020 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligation & Disclosure Requirements)
30/10/2020 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations An
28/10/2020 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Shareholding for the Period Ended September 30 2020
20/10/2020 | bse
Quick Links for Aspira Pathlab & Diagnostics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
